ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 277 filers reported holding ICU MED INC in Q3 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $829,000 | -8.7% | 4,500 | 0.0% | 0.08% | -24.3% |
| Q1 2020 | $908,000 | +7.8% | 4,500 | 0.0% | 0.11% | +33.8% |
| Q4 2019 | $842,000 | +17.3% | 4,500 | 0.0% | 0.08% | +8.1% |
| Q3 2019 | $718,000 | -36.7% | 4,500 | 0.0% | 0.07% | -37.3% |
| Q2 2019 | $1,134,000 | +5.3% | 4,500 | 0.0% | 0.12% | +1.7% |
| Q1 2019 | $1,077,000 | +4.3% | 4,500 | 0.0% | 0.12% | -9.4% |
| Q4 2018 | $1,033,000 | -18.8% | 4,500 | 0.0% | 0.13% | -4.5% |
| Q3 2018 | $1,272,000 | -3.7% | 4,500 | 0.0% | 0.13% | -10.7% |
| Q2 2018 | $1,321,000 | +16.3% | 4,500 | 0.0% | 0.15% | +15.4% |
| Q1 2018 | $1,136,000 | +16.9% | 4,500 | 0.0% | 0.13% | +21.5% |
| Q4 2017 | $972,000 | +16.3% | 4,500 | 0.0% | 0.11% | +12.6% |
| Q3 2017 | $836,000 | +7.7% | 4,500 | 0.0% | 0.10% | +3.3% |
| Q2 2017 | $776,000 | +13.0% | 4,500 | 0.0% | 0.09% | +9.5% |
| Q1 2017 | $687,000 | +3.6% | 4,500 | 0.0% | 0.08% | -2.3% |
| Q4 2016 | $663,000 | +16.5% | 4,500 | 0.0% | 0.09% | +16.2% |
| Q3 2016 | $569,000 | +12.2% | 4,500 | 0.0% | 0.07% | +12.1% |
| Q2 2016 | $507,000 | +8.3% | 4,500 | 0.0% | 0.07% | +6.5% |
| Q1 2016 | $468,000 | -7.9% | 4,500 | 0.0% | 0.06% | -11.4% |
| Q4 2015 | $508,000 | +3.0% | 4,500 | 0.0% | 0.07% | +1.4% |
| Q3 2015 | $493,000 | +14.7% | 4,500 | 0.0% | 0.07% | +27.8% |
| Q2 2015 | $430,000 | +2.6% | 4,500 | 0.0% | 0.05% | +3.8% |
| Q1 2015 | $419,000 | +13.6% | 4,500 | 0.0% | 0.05% | +13.0% |
| Q4 2014 | $369,000 | +27.7% | 4,500 | 0.0% | 0.05% | +24.3% |
| Q3 2014 | $289,000 | +5.5% | 4,500 | 0.0% | 0.04% | +5.7% |
| Q2 2014 | $274,000 | -49.1% | 4,500 | -50.0% | 0.04% | -2.8% |
| Q1 2014 | $538,000 | +87.5% | 9,000 | +100.0% | 0.04% | -5.3% |
| Q4 2013 | $287,000 | -6.2% | 4,500 | 0.0% | 0.04% | -13.6% |
| Q3 2013 | $306,000 | -5.6% | 4,500 | 0.0% | 0.04% | -10.2% |
| Q2 2013 | $324,000 | – | 4,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 460,038 | $92,822,000 | 7.19% |
| NUANCE INVESTMENTS, LLC | 526,008 | $106,133,000 | 3.68% |
| PFM Health Sciences, LP | 202,339 | $40,826,000 | 3.35% |
| CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $4,035,000 | 3.19% |
| PURA VIDA INVESTMENTS, LLC | 126,784 | $25,581,000 | 3.04% |
| Sandhill Capital Partners LLC | 107,817 | $21,754,000 | 2.92% |
| PURA VIDA INVESTMENTS, LLC | 121,500 | $24,515,000 | 2.91% |
| KIRR MARBACH & CO LLC /IN/ | 24,126 | $4,868,000 | 2.08% |
| Penn Capital Management Company, LLC | 44,620 | $9,053,000 | 1.49% |
| GW&K Investment Management, LLC | 351,543 | $70,930,000 | 1.25% |